384
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Changes in Mood, Anxiety, and Cognition with Polycystic Ovary Syndrome Treatment: A Longitudinal, Naturalistic Study

, , ORCID Icon, , ORCID Icon & ORCID Icon
Pages 2703-2712 | Received 04 Aug 2022, Accepted 10 Nov 2022, Published online: 15 Nov 2022

References

  • Conway G, Dewailly D, Diamanti-Kandarakis E, et al. The polycystic ovary syndrome: a position statement from the European society of endocrinology. Eur J Endocrinol. 2014;171:P1–P29. doi:10.1530/EJE-14-0253
  • Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31:2841–2855. doi:10.1093/humrep/dew218
  • Riestenberg C, Jagasia A, Markovic D, Buyalos RP, Azziz R. Health care-related economic burden of polycystic ovary syndrome in the United States: pregnancy-related and long-term health consequences. J Clin Endocrinol Metab. 2022;107:575–585. doi:10.1210/clinem/dgab613
  • Ndefo UA, Eaton A, Green MR. Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches. Pharmacol Ther. 2013;38:336–355.
  • Brutocao C, Zaiem F, Alsawas M, Morrow AS, Murad MH, Javed A. Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis. Endocrine. 2018;62:318–325. doi:10.1007/s12020-018-1692-3
  • Dokras A, Stener-Victorin E, Yildiz BO, et al. Androgen excess-polycystic ovary syndrome society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. Fertil Steril. 2018;109:888–899. doi:10.1016/j.fertnstert.2018.01.038
  • Sukhapure M, Eggleston K, Douglas K, Fenton A, Frampton C, Porter RJ. Free testosterone is related to aspects of cognitive function in women with and without polycystic ovary syndrome. Arch Womens Ment Health. 2022;25:87–94. doi:10.1007/s00737-021-01158-9
  • Douglas KM, Fenton AJ, Eggleston K, Porter RJ. Rate of polycystic ovary syndrome in mental health disorders: a systematic review. Arch Womens Ment Health. 2022;25:9–19. doi:10.1007/s00737-021-01179-4
  • Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017;32:1075–1091. doi:10.1093/humrep/dex044
  • Yin X, Ji Y, Chan CLW, Chan CHY. The mental health of women with polycystic ovary syndrome: a systematic review and meta-analysis. Arch Womens Ment Health. 2021;24:11–27. doi:10.1007/s00737-020-01043-x
  • Hung J-H, Hu L-Y, Tsai S-J, et al. Risk of psychiatric disorders following polycystic ovary syndrome: a nationwide population-based cohort study. PLoS One. 2014;9:e97041. doi:10.1371/journal.pone.0097041
  • Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33:1602–1618. doi:10.1093/humrep/dey256
  • Barnard L, Balen AH, Ferriday D, Tiplady B, Dye L. Cognitive functioning in polycystic ovary syndrome. Psychoneuroendocrinology. 2007;32:906–914. doi:10.1016/j.psyneuen.2007.06.010
  • Schattmann L, Sherwin BB. Testosterone levels and cognitive functioning in women with polycystic ovary syndrome and in healthy young women. Horm Behav. 2007;51:587–596. doi:10.1016/j.yhbeh.2007.02.007
  • Porter RJ, Robinson LJ, Malhi GS, Gallagher P. The neurocognitive profile of mood disorders–a review of the evidence and methodological issues. Bipolar Disord. 2015;17:21–40. doi:10.1111/bdi.12342
  • Douglas KM, Gallagher P, Robinson LJ, et al. Prevalence of cognitive impairment in major depression and bipolar disorder. Bipolar Disord. 2018;20:260–274. doi:10.1111/bdi.12602
  • Ferreri F, Lapp LK, Peretti CS. Current research on cognitive aspects of anxiety disorders. Curr Opin Psychiatry. 2011;24:49–54. doi:10.1097/YCO.0b013e32833f5585
  • Hamson DK, Roes MM, Galea LA. Sex hormones and cognition: neuroendocrine influences on memory and learning. Compr Physiol. 2011;6:1295–1337.
  • Rasgon NL, Rao RC, Hwang S, et al. Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. J Affect Disord. 2003;74:299–304. doi:10.1016/S0165-0327(02)00117-9
  • Kashani L, Omidvar T, Farazmand B, et al. Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression. Psychoneuroendocrinology. 2013;38:767–776.
  • Dokras A, Sarwer DB, Allison KC, et al. Weight loss and lowering androgens predict improvements in health-related quality of life in women with PCOS. J Clin Endocrinol Metab. 2016;101:2966–2974. doi:10.1210/jc.2016-1896
  • Cinar N, Harmanci A, Demir B, Yildiz BO. Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study. Hum Reprod. 2012;27:1840–1845. doi:10.1093/humrep/des113
  • Marsh CA, Berent-Spillson A, Love T, et al. Functional neuroimaging of emotional processing in women with polycystic ovary syndrome: a case-control pilot study. Fertil Steril. 2013;100(200–7):e1. doi:10.1016/j.fertnstert.2013.02.054
  • Schattmann L, Sherwin BB. Effects of the pharmacologic manipulation of testosterone on cognitive functioning in women with polycystic ovary syndrome: a randomized, placebo-controlled treatment study. Horm Behav. 2007;51:579–586. doi:10.1016/j.yhbeh.2007.02.002
  • Eshre TR; ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25.
  • Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33; quiz 4–57.
  • Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–370. doi:10.1111/j.1600-0447.1983.tb09716.x
  • Lezak M. Neuropsychological Assessment. USA: Oxford University Press; 2004.
  • Nelson HE, Willison J. National Adult Reading Test (NART). Nfer-Nelson Windsor; 1991.
  • Bourke C, Porter RJ, Carter JD, et al. Comparison of neuropsychological functioning and emotional processing in major depression and social anxiety disorder subjects, and matched healthy controls. Aust N Z J Psychiatry. 2012;46:972–981. doi:10.1177/0004867412451502
  • Snyder PJ, Jackson CE, Piskulic D, Olver J, Norman T, Maruff P. Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication. Psychiatry Res. 2008;160:316–326. doi:10.1016/j.psychres.2007.07.011
  • Delis DC, Kaplan E, Kramer JH. Delis-Kaplan Executive Function System (D-KEFS). San Antonio, Texas: The Psychological Corporation; 2001.
  • Benton AL, Hamsher K. Multilingual Aphasia Examination. Iowa City: AJA Associates; 1989.
  • Wechsler D. Wechsler Adult Intelligence Scale (WAIS-IV). 4th ed. San Antonio, Texas: Pearson Education Inc; 2008.
  • Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84:3666–3672. doi:10.1210/jcem.84.10.6079
  • IBM Corp. IBM SPSS Statistics for Windows. 19th ed. Armonk, NY: IBM Corp; 2010.
  • von Werne Baes C, de Carvalho Tofoli SM, Martins CMS, Juruena MF. Assessment of the hypothalamic–pituitary–adrenal axis activity: glucocorticoid receptor and mineralocorticoid receptor function in depression with early life stress–a systematic review. Acta Neuropsychiatr. 2012;24:4–15. doi:10.1111/j.1601-5215.2011.00610.x
  • Abdallah MS, Mosalam EM, Zidan A-A-A, et al. The antidiabetic metformin as an adjunct to antidepressants in patients with major depressive disorder: a proof-of-concept, randomized, double-blind, placebo-controlled trial. Neurotherapeutics. 2020;17:1897–1906. doi:10.1007/s13311-020-00878-7
  • AlHussain F, AlRuthia Y, Al-Mandeel H, et al. Metformin improves the depression symptoms of women with polycystic ovary syndrome in a lifestyle modification program. Patient Prefer Adherence. 2020;14:737. doi:10.2147/PPA.S244273